Research and Publication Highlights

Below is a summary of research and publication highlights from the NIPC/University of Galway partnership. This section will be updated over time and we will include more information on our research programmes, funding sources, and research collaborations.

Research Study Highlights


This is currently our flagship research project. Members of our team have been leading surveys evaluating the quality of secondary and primary prevention of cardiovascular disease in Europe for more than two decades and our most recent survey, EUROASPIRE V (2016-18), across 27 countries was published in 2019. We now plan to expand EUROASPIRE to other geographies, The overall objective of INTERASPIRE is to describe the management of cardiovascular risk factors, and current use of cardioprotective medications, in relation to international and national guideline standards on prevention of cardiovascular disease. The survey will be conducted in 30 selected countries (2019-21, recruiting over 12,000 participants), from the 5 WHO regions outside Europe, and a pilot study is being conducted in Argentina and Malaysia in late 2019. Find out more here

The main objectives of CVD prevention are to reduce cardiovascular morbidity and mortality, improve quality of life, and increase life expectancy. The European Society of Cardiology together with other partner Societies has engaged in a comprehensive programme of CVD prevention in clinical practice since 1994. Guidelines on this important topic have been developed and updated at regular intervals over the last 18 years: 1994, 1998, 2003, 2007, 2012 and 2016. The aim of the Joint European Societies Guidelines (JES) on cardiovascular disease prevention is to improve the practice of preventive cardiology by encouraging the development of national guidance on cardiovascular disease prevention and its communication, implementation and evaluation through national societies in each country. Find out more here


This is the first nationally representative Irish study of secondary prevention among patients with CHD. Over 600 patients were enrolled at 9 sites across Ireland, with the results presented at the 2019 Irish Cardiac Society meeting.

Publication Highlights